Senior Vice President, R&D of Travere Therapeutics, Inc. (U.S.: Nasdaq:TVTX), Rote William E., sells 2,500 shares worth $68,500
According to Travere Therapeutics, Inc.'s most recent Statement Of Changes In Beneficial Ownership - Form 4 filing with the SEC dated Jan 12 04:06 PM, company Senior Vice President, R&D, Rote William E. disclosed selling 2,500 shares at a cost of $27.40. At the time of this transaction (Jan 11), this trade was worth $68,500 in total. As of Jan 11, Rote William E. now owns 38,395 shares in total worth about $1,004,797.15.
For the last few recent trades made by Travere Therapeutics, Inc. (U.S.: Nasdaq:TVTX) Senior Vice President, R&D, Rote William E., we have the following information:
- SEC Form 4 filing: Aug 17: Sold 1,407 shares at the rate of $17.12 per share. Total worth of this trade was $24,085. Total number of shares owned as of Aug 17 were 35,731
Posted by
George Daniels
on Thursday January 13 2022, 1:32 PM EST.
All trademarks acknowledged.
Filed under Business, Stocks.
Comments and Trackbacks closed.
Follow responses:
RSS 2.0
